Recent evidence has demonstrated that specific variants of the ATM gene are associated not only with an increased risk of breast cancer development and poorer clinical outcomes, but also with similar associations observed in esophageal SCC and colorectal cancer [47, 48, 49]. The gene discussed is ATM; the disease is colorectal cancer.